Tag: Cyxone

July 5, 2019 Off

Cyxone asks Polich CEC to start second phase testing of its candidate Rabeximod in RA

Swedish Cyxone has submitted an application to the CEC in Poland for permission to start a clinical phase IIb trial with Cyxone’s drug candidate Rabeximod in RA , marking the first regulatory step towards the initiation of the study.

June 20, 2019 Off

Cyxone starts in-human testing of its multiple sclerosis drug candidate

By Dino Mustafić

Swedish biotech company focused on autoimmune diseases, Cyxone is testing its drug candidate T20K, its first-in-human, phase I, clinical trial, for the treatment of multiple sclerosis (MS).